Nobex raises $35 million

Drug delivery company Nobex raised $35 million in a Series F round led by AEA Investors. Other investors included EndPoint Late Stage Fund I; HealthCap; and a group of Taiwan-based venture capital firms. The company said it will use the funds for its clinical projects, which include Oratonin, an oral version of calcitonin expected to enter Phase II testing by year end. ...